REQUEST A DEMO
Total
USD $0.00
Search more companies

Qualipharm Laboratorio Farmaceutico S.A. (Ecuador)

Main Activities: Toilet Preparation Manufacturing
Full name: Qualipharm Laboratorio Farmaceutico S.A. Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Qualipharm Laboratorio Farmacéutico S.A is a national manufacturer of health, cosmetics, and hygiene products. The company offers development, production, logistics, technical advice, and regulation services. With an international presence, it focuses on providing reliable, agile, and innovative services to its customers.

Headquarters
Av. Manuel Cordova Galarza Oe4-175, Fierro Inmobiliaria Bldg.
Quito; Pichincha;

Contact Details: Purchase the Qualipharm Laboratorio Farmaceutico S.A. report to view the information.

Website: http://www.qualipharmlab.com

Basic Information
Total Employees:
Purchase the Qualipharm Laboratorio Farmaceutico S.A. report to view the information.
Outstanding Shares:
Purchase the Qualipharm Laboratorio Farmaceutico S.A. report to view the information.
Registered Capital:
Purchase the Qualipharm Laboratorio Farmaceutico S.A. report to view the information.
Incorporation Date:
October 24, 2008
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Qualipharm Laboratorio Farmaceutico S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
27.61%
Total operating revenue
26.92%
Operating profit (EBIT)
45.18%
EBITDA
20.36%
Net Profit (Loss) for the Period
125.81%
Total assets
13.75%
Total equity
54.16%
Operating Profit Margin (ROS)
2.1%
Net Profit Margin
4.18%
Return on Equity (ROE)
10.77%
Debt to Equity Ratio
-60.72%
Quick Ratio
0.34%
Cash Ratio
-0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?